Providing Information about the Open Therapeutics’ Therapoid Open Science Platform. Cincinnati, OH — May 16th, 2022 — Open Therapeutics, an open science company, announces its…
Cincinnati, OH — May 4th, 2020 — Open Therapeutics, an open science therapeutic collaboration platform company announces its technology development alliance with Kudelski Security, the…
Jason E. Barkeloo will attend invitation-only blockchain open science meetings, which will include meeting ultra high networth investors. These meetings are inline with Open Therapeutics…
Timmaron Group of Minnesota invests in Open Therapeutics, LLC Open Therapeutics, LLC owns Therapoid. Therapoid is a scientific collaboration platform that crowdsources scientists, particularly…
Open Therapeutics Receives Oklahoma Medical Research Foundation’s Dormant Intellectual Property. The intellectual property is available on the scientific collaboration platform, Therapoid™. Minneapolis, MN–…
Open Therapeutics Announced as a Winner of Freedom from Cancer Startup Challenge Minneapolis, MN and Bethesda, MD – July 26, 2018 – Open Therapeutics…
Open Therapeutics and doDOC™ Partner to Integrate doDOC™ Content Management System into Therapoid™. Innovative manuscript development tool to be integrated into scientific collaboration platform.…
A number of Dr. Cripe’s team is presenting at the 11th International Oncolytic Virus Conference 2018, 9-12 April 2018, at Oxford University, UK: https://iovc.ada.wats-on.co.uk/Home.aspx …
OnPAR and Open Therapeutics Partner for Enhancing the Flow of Grants to Researchers Will collaborate to help scientists gain funding for previously highly…
